Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
Work
Year: 2024
Type: article
Abstract: Background Cachexia is characterized by weight loss and decline in muscle mass and function and is a poor prognostic factor among patients with cancer. Patients with metastatic EGFR-mutant non-small ... more
Source: The Oncologist
Institutions Columbia University Irving Medical Center, Cancer Genetics (United States), Columbia University
Cites: 36
Cited by: 1
Related to: 10
FWCI:
Citation percentile (by year/subfield):
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $3,494